Nurexone Biologic Inc (NRX.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Operating Expenses | 1,164 | 1,060 | 719 | 841 | 988 |
| Operating Income | -1,164 | -1,060 | -719 | -841 | -988 |
| Other Income | 6 | 20 | 14 | -173 | -53 |
| Pre-tax Income | -1,158 | -1,040 | -705 | -1,014 | -1,041 |
| Net Income Continuous | -1,158 | -1,040 | -705 | -1,014 | -1,041 |
| Net Income | $-1,158 | $-1,040 | $-705 | $-1,014 | $-1,041 |
| EPS Basic Total Ops | -0.03 | -0.02 | -0.02 | -0.02 | -0.03 |
| EPS Basic Continuous Ops | -0.03 | -0.02 | -0.02 | -0.02 | -0.03 |
| EPS Diluted Total Ops | -0.03 | -0.02 | -0.02 | -0.02 | -0.03 |
| EPS Diluted Continuous Ops | -0.03 | -0.02 | -0.02 | -0.02 | -0.03 |
| EBITDA(a) | $-1,146 | $-1,054 | $-713 | $-3,435 | $-986 |